Publications by authors named "Masatoki Watanabe"

Intervertebral disc (IVD) degeneration is a major cause of low back pain. However, treatments directly approaching the etiology of IVD degeneration and discogenic pain are not yet established. We previously demonstrated that intradiscal implantation of cell-free bioresorbable ultra-purified alginate (UPAL) gel promotes tissue repair and reduces discogenic pain, and a combination of ultra-purified, Good Manufacturing Practice (GMP)-compliant, human bone marrow mesenchymal stem cells (rapidly expanding clones; RECs), and the UPAL gel increasingly enhanced IVD regeneration in animal models.

View Article and Find Full Text PDF

Background: Articular cartilage repair remains challenging despite the availability of techniques, including autologous chondrocyte implantation (ACI) for repairing large cartilage defects. Platelet-rich plasma (PRP) therapy, a novel therapy focused on chondrocyte regeneration, needs to be investigated regarding its potential to improve the outcomes of ACI.

Purpose: To examine the effect of PRP therapy on the outcomes of cartilage repair using the ACI procedure in a rabbit model of knee joint cartilage damage.

View Article and Find Full Text PDF
Article Synopsis
  • Lumbar intervertebral disc (IVD) herniations lead to significant disability, and traditional treatments like discectomy can worsen IVD degeneration due to low self-repair abilities.
  • A new study investigated the use of a bioresorbable gel combined with human bone marrow mesenchymal stem cells (RECs) for IVD regeneration after discectomy in a sheep model.
  • Results showed that the combination therapy significantly improved gene expression linked to IVD regeneration and suggests potential for treating degenerative IVD herniations in humans.
View Article and Find Full Text PDF

Although intracardiac injection or intracoronary delivery of mesenchymal stem cells (MSCs) has been reported, there have been few studies on the intravenous injection of MSCs, particularly in Japan. Five patients with left ventricular ejection fraction (LVEF) ≤45% received 1.0×10 MSCs intravenously.

View Article and Find Full Text PDF

Two distinct cDNAs corresponding to two zebrafish protein O-mannosyltransferase genes, zPOMT1 and zPOMT2, were cloned from early developmental embryos. Gene expression analysis revealed that zPOMT1 and zPOMT2 were expressed in similar patterns during early embryonic development and in all adult tissues. To study the regulation of zPOMT1 and zPOMT2 mRNA distribution during zebrafish embryogenesis, we injected enhanced green fluorescent protein (EGFP) mRNA fused to the 3'untranslated regions of each zPOMT gene.

View Article and Find Full Text PDF